Benchmarking Imputation Methods for Single-Cell RNA Sequencing Data Using Peripheral Blood Mononuclear Cells from Acute Myocardial Infarction Patients

Acute myocardial infarction (AMI) remains one of the leading causes of mortality worldwide, and the following post-effects, such as post-AMI inflammation and tissue repair, involve peripheral blood mononuclear cells playing a critical role. The influence of imputation methods in biological data is assessed with respect to high-resolution single-cell RNA sequencing (scRNAseq) data relevant to these cells. Still scRNAseq data often encounter a lot of dropout events, leading to sparse and noisy datasets, hampering downstream results. To assess the influence of the missingness in the data, we artificially impose different levels of dropout in available scRNAseq data by leveraging various imputation techniques. Specifically, we introduce artificial missingness at 10%, 20%, and 30% levels under a missing completely at random (MCAR) framework, repeated across 10 independent runs. We benchmarked six imputation strategies - MAGIC, IterativeImputer, KNNImputer, Mean Imputation, SoftImpute, and a Generative adversarial network (GAN) - based approaches using multiple evaluation metrics: marker gene preservation, clustering consistency (Adjusted Rand Index - ARI), gene-wise correlation with ground truth, and structural separation (silhouette scores). The results clearly underline that no single imputation method dominated across all metrics. Overall, Mean and KNN imputers showed limited recovery across all benchmarks. GAN excelled in global transcriptional recovery and SoftImpute in preserving biologically meaningful cell-type signals. Our results highlight the importance of selecting the imputation methods as part of the pre-processing step towards the downstream biological questions related to transcriptome recovery, detection of marker genes, or maintaining cell-type-specific resolution.